You are here
bioMérieux’s Myla® Named as Finalist in the 2012 Medical Design Excellence Awards
12 Aprile, 2012A world leader in in vitro diagnostics, bioMérieux today announced that its microbiology middleware, Myla® has been selected as a finalist in the In Vitro Diagnostics category of the Medical Design Excellence Awards (MDEA)competition. Myla is an innovative microbiology middleware solution that offers consolidated interfacing, workflow optimization and information management. Myla is browser-based and consolidates information that can impact patient care and efficiency from ID/AST and blood culture testing in a single interface for the LIS. Users can access Myla remotely from anywhere on their network.
A world leader in in vitro diagnostics, bioMérieux today announced that its microbiology middleware, Myla® has been selected as a finalist in the In Vitro Diagnostics category of the Medical Design Excellence Awards (MDEA)competition. Myla is an innovative microbiology middleware solution that offers consolidated interfacing, workflow optimization and information management. Myla is browser-based and consolidates information that can impact patient care and efficiency from ID/AST and blood culture testing in a single interface for the LIS. Users can access Myla remotely from anywhere on their network.